B
OTH ATEOPINE and isoproterenol (Isuprel) increase the cardiac output when given intravenously to normal recumbent subjects.
1 ' 2 In the present investigation, the changes in the circulation induced by these drugs have been studied by simultaneous injection of Evans blue dye (T-1824) into the superior vena cava and radioactive iodinated (I 131 ) human serum albumin into either the antecubital or femoral vein. In addition to denning and comparing some of the actions of these drugs on the circulation, observations were made on the effects of increased cardiac output on the volume and distribution of blood in which the indicator is diluted.
Methods
Twenty studies were performed on normal youngmale subjects in the supine position and postabsorptive state. In all subjects, a woven silk catheter was introduced into the right antecubital vein and its tip placed in the superior vena cava near the right atrium. This was utilized for injection of Evans blue dye (T-1S24) and measurement of central venous pressure. An 18-gauge Cournand needle was then placed in a peripheral vein: a large, freely flowing medial antecubital vein in seven cases and the right femoral vein in 13 cases. This peripheral venous needle was used for the injection of a second indicator, radioiodinated human serum albumin (IHSA) containing 15 to 20 /ic. of activity in a 1.5-to 2.0-ml. volume.
Another 18-gauge Cournand needle was placed in the left braehial artery to serve as a common or single sampling site for the serial collection of timed (two-second) arterial blood samples containing the two simultaneously injected indicators. The serially collected arterial samples were analyzed in the following manner: (1) T-1824 concentration was measured, using a Beckman spectrophotometer, and (2) radioactivity was measured using a well scintillation counter according to the method of Smith and Hoopler. 3 From the above analyses, using the single series of arterial samples, two time-concentration curves were constructed for the simultaneously injected central and peripheral indicators. The StewartHamilton formula 4 was applied to these curves for the determination of cardiac output and mean transit time.
The total blood volume was determined in all subjects using IHSA as the indicator. The sample was drawn 10 minutes after injection.
Pressures in the braehial artery and superior vena cava were recorded by Statham strain-gauge transducers and a multichannel recording unit. The second intercostal space, 5 cm. below the angle of the sternum, was the reference point for all pressure determinations. Peripheral resistance was expressed in arbitrary units obtained by dividing the mean arterial pressure by the cardiac output per minute. Electronic integration was used in measuring the mean arterial and mean central venous pressures. A standard limb lead electrocardiogram was used to measure the heart rate during time of cardiac output determination.
T-1824 was injected into the superior vena cava via the catheter in all subjects. In seven studies with atropine, IHSA was injected through the antecubital vein simultaneously with the central dye. Observations were made in a control state and again one and a half to two minutes after the completion of the intravenous (via catheter) administration of 2 mg. atropine sulfate injected over a one-minute period in a 5-nil. volume. In seven other studies with atropine, the same tech- nique was followed, except that the peripheral venous injection of IHSA was made into the right femoral vein instead of the antecuhital vein.
In six subjects, the effects of isoproterenol were studied. The injection of T-1S24 was made into the superior vena eava and the IHSA into the femoral vein. Isoproterenol was given intravenously in a forearm vein in a concentration of 1 /xg./ml. The drip was administered at a rate of about 1 ml. per minute. Cardiac output was then determined between the fifth and the tenth minute in the steady state of widened pulse pressure and slight tachycardia produced by this drug.
Results
When the indicator was injected into a femoral or antecubital vein, the calculated value for cardiac output tended to be greater than when the indicator was injected into the superior vena cava. The difference was usually small and assumed statistical significance only in a large series. With peripheral injection, a variable portion of the indicator injected does not reach the heart in time to be included in the initial portion of the curve from which the output calculation is made. The statistical treatment of all our data on peripheral and central injections has been discussed elsewhere. 5 The calculated increase in cardiac output produced by the two drugs was the same when the observations were made from the same injection site before and after the drugs.
Atropine (tables 1 and 2) in the dosage given increased the mean heart rate from 65 to 113 beats per minute. The mean increase in cardiac output was 2.5 L./min. The heart rate increased relatively more than the cardiac output. This increase resulted in a fall in stroke volume. The total blood volume was unchanged. The arterial systolic pressure rose slightly in nine of the 14 subjects, and the average diastolic pressure rose 12 mm. Hg. The calculated peripheral resistance decreased in all subjects, and the average fall in central venous pressure was 3.3 cm. H 2 O.
Isoproterenol (table 3) , in the dosage used, produced approximately the same degree of rise in cardiac output and a slightly smaller mean fall in central venous pressure than did the atropine. In contrast to atropine, the stroke volume rose significantly with isopro- terenol. The mean stroke volume before isoproterenol was 83 ml.; the mean stroke volume after the drug was 105 ml. The mean pulse rate increased nine beats per minute, and the average mean arterial pressure fell 4 mm. Hg. In all subjects, the systolic pressure increased, while the diastolic pressure fell. The decrease in peripheral resistance with isoproterenol was more marked than with atropine. The total blood volume was unchanged.
The cardiac output and mean transit time measurements from the peripheral vein and superior vena eava were compared before and after the administration of atropine and isoproterenol. When the dye was injected into the superior vena eava, the increased cardiac output produced by the drugs had no effect on the peak concentration of the dye collected from the artery. The shortening of the mean transit time was proportional to the increase in cardiac output. These relationships were different when the indicator was injected into the antecubital or femoral veins. At both peripheral sites, the administered drugs caused Circulation Research. Volume IX, September 1961 a rise in peak concentration of the indicator in the samples collected from the artery and a shortening of the mean transit time out of proportion to the increase in cardiac output.
Discussion
The change in mean central venous pressure was definitely related to the administration of a drug. The magnitude of the fall clearly separated the action of the drug from the spontaneously occurring changes in central venous pressure.
With atropine there were no observed changes in respiratory rate or depth to suggest that the decrease in central venous pressure resulted from an increase in negative pressure within the thorax. Isoproterenol, however, does increase ventilation. Eckstein and Hamilton" have shown that the fall in atrial pressure produced by isoproterenol is uot accompanied by a fall in esophageal pressure, and from this they conclude that a fall in intrapleural pressure cannot account for the observed decrease in central venous pressure. Prom our studies, the irregular and minimal changes in blood volume and the rapidity of the change in central venous pressure following the administration of the drugs indicate that changes in total blood volume are not of primary importance. The fall in central A'enous pressure is compatible with either a change in the pressure volume characteristics of the venous system, or redistribution of blood within the vascular system, or a combination of these two.
The atropine-induced rise in cardiac output was associated with an increase in pressure gradient between the arterial system and the superior vena cava. With isoprotereuol, the gradient was either unchanged or slightly decreased.
It is of interest that the central venous pressure was lower in the presence of an increased cardiac output and that this relationship was present both with atropine, which increased mean arterial pressure and lowered stroke volume, and with isoproterenol, which lowered mean arterial pressure and increased stroke volume. From the present data, one cannot ascertain whether the peripheral flow or the cardiac output increased first or whether both changes occurred together. The fall in peripheral resistance with the rise in cardiac output indicated that the overall response to both drugs was one of vasodilatation. The increase in capacity of the system in the vascular beds where vasodilatation occurred may be sufficient to account for the observed fall in central venous pressure.
The response of the heart to the two drugs was similar in that the rise in output was of the same order of magnitude, but the method of adaptation resulting from the rise in output was quite different. With atropine, the ventricles received less blood during each diastole ; with isoproterenol, the ventricles received more blood with each diastole. In both instances, the right ventricle had no difficulty in moving forward a greater volume of blood with a lower mean central venous pressure.
Prom examination of the data, we can conclude that changes occurred in the periphery and in the heart, that the change in the periphery was that of overall vasodilatation, that the heart was able to accept more blood per minute with a decreased central venous pressure, and that, depending on the situation, Circulation Research, Volume IX. September 1961 the heart could vary its output by increasing the stroke volume or by increasing the rate without au increase in stroke volume. Prom these data, collected at two periods of circulatory equilibrium, we cannot define the events occurring in passing from one state to another. We cannot separate primary effects on cardiac output with secondary peripheral vasodilatation from primary effects on peripheral vasodilatation with secondary increases in cardiac output. We do not know to what degree the first increase in output is dependent on increased venous return, even though we know that a sustained increase in output must depend on a sustained increase in venous return.
In a given subject, changes in the mean transit time between the superior vena cava and the brachial artery were proportional to changes in cardiac output. The fact that the indicator can be moved more rapidly from the superior vena cava through both chambers of the heart and the pulmonary circulation to the point of arterial sampling without increasing the diluting volume or changing the peak concentration is of interest. It suggests that the increase in flow is accomplished without much change in the relative pattern of flow in the areas traversed. The possibility that a change in the diluting volume in the lung occurred and was masked by a change in distribution of the pattern of arterial flow cannot be excluded by these data. 7 ' s With peripheral injection of the indicators, changes in mean transit time caused by the drugs were not proportional to the changes in cardiac output. Increasing the cardiac output caused an increase in the peak concentration of the indicator in the blood from the brachial artery. These data suggest that both drugs produced changes in the patterns of peripheral blood flow.
Summary
Two milligrams of atropine given intravenously increased the cardiac output, the mean arterial pressure, and the heart rate and lowered the central venous pressure, stroke output, and peripheral resistance. Isoproterenol given intravenously at the rate of 1 fj.g. per Circulation Research, Volume IX, September 1961 minute increased the cardiac output with only an average increase in pulse rate of nine beats per minute. The stroke volume was increased. The central venous pressure and the peripheral resistance were decreased. These observations on the circulation were made in the steady state. They demonstrate that the minute output of the heart can be increased by either a rise in rate or an increase in stroke volume in the presence of a fall in central venous pressure. They do not define the order of events leading to the steady state. When the indicator was placed in the superior vena cava, neither atropine nor isoproterenol changed the volume in which the indicator was diluted during its first circulation. Both atropine and isoproterenol decreased the volumes in which the indicators were diluted when they were injected into the antecubital or femoral veins.
